Skalen K, Gustafsson M, Rydberg EK, Hulten LM, Wiklund O, Innerarity TL, Boren J
Potential Cardiovascular Benefits for Ozempic Patients Ozempic may effect effective blood sugar control, cause weight loss as an effect, and provides convenient once-weekly dosing, while the cons may involve side effects like nausea, fatigue, or stomach pain, as well as high costs for those without insurance
Neuropsychopharmacol (2006) 31(6):112334
Ozempic is FDA-approved for type 2 diabetes and to reduce the risk of kidney disease progression and cardiovascular death in adults with type 2 diabetes, and as of January 2025, for chronic kidney disease
doi: 10.6133/apjcn.202401_33(1).0008 94
Ghrelin Receptor Pathway (Ipamorelin) Ipamorelin activates GHS-R1a receptors via an entirely different molecular pathway, using calcium-channel signaling to independently stimulate GH release